Yahong Peng

Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years

Brandon Essink, Charu Sabharwal, Kevin Cannon et al. · Clinical Infectious Diseases · 2021 · 172 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial

Judith Absalon, Nathan Segall, Stan L. Block et al. · The Lancet Infectious Diseases · 2020 · 130 citations · Full text

Veterinary Medicine, Immunology, Maternal Health +16

Two Phase 2 Multiple Ascending–Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer’s Disease

Florence Pasquier, Carl Sadowsky, Ann R Holstein et al. · Journal of Alzheimer s Disease · 2016 · 101 citations

Veterinary Medicine, Immunology, Pharmacology +17

Growth hormone secretagogue MK-677

Jeffrey Sevigny, Jillian Ryan, C H van Dyck et al. · Neurology · 2008 · 88 citations

Medicine, Endocrinology, Neurology +17

A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccination

Kevin Cannon, Charles Elder, Mariano Young et al. · Vaccine · 2021 · 83 citations

Veterinary Medicine, Immunology, Infectious Diseases +16